Zai Lab Ltd (ZLAB) shareholders
Close on Nov 16, 2026Market cap $3.65BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Wellington Management Company LLP Joint filing with Wellington Management Group LLP (9.20%), Wellington Group Holdings LLP (9.20%) and 1 more | 100,622,628 | 8.20% | 13G (passive) amendment | Dec 31, 2024 |
| FMR LLC Joint filing with Abigail P. Johnson (6.40%) | 71,683,793 | 6.40% | 13G (passive) amendment | Sep 30, 2025 |
| Wellington Management Group LLP Joint filing with Wellington Group Holdings LLP (6.40%), Wellington Investment Advisors Holdings LLP (6.40%) and 1 more | 70,302,416 | 6.40% | 13G (passive) amendment | Mar 31, 2025 |
| Roderick Wong Joint filing with RTW Investments, LP (6.30%) | 69,590,320 | 6.30% | 13G (passive) | Dec 31, 2025 |
| Wellington Investment Advisors Holdings LLP Joint filing with Wellington Management Group LLP (6.00%), Wellington Group Holdings LLP (6.00%) and 1 more | 67,415,323 | 6.00% | 13G (passive) | Sep 30, 2025 |
| QM11 Limited Joint filing with Qiming Corporate GP IV, Ltd. (5.97%), Qiming GP IV, L.P (5.79%) and 1 more | 66,329,320 | 5.97% | 13G (passive) amendment | Jun 30, 2025 |
| Chen Yu | 59,130,750 | 5.30% | 13G (passive) | Jun 2, 2026 |
| Rajeev Shah Joint filing with RA Capital Management, L.P. (5.20%), Peter Kolchinsky (5.20%) and 1 more | 57,435,330 | 5.20% | 13G (passive) | Mar 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ZLAB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Rtw Investments, LP | 6,574,032 | 1.53% | $124.91M | – | 1.07% |
| TCG Crossover Management, LLC | 6,137,627 | 1.43% | $116.61M | New | 2.80% |
| Ra Capital Management, L.P. | 5,743,533 | 1.33% | $109.13M | +36,271 | 0.95% |
| ADAR1 Capital Management, LLC | 3,369,034 | 0.78% | $64.01M | +1,943,667 | 2.93% |
| FMR LLC | 2,815,214 | 0.65% | $53.49M | +1,552,823 | 0.00% |
| Goldman Sachs Group Inc | 2,315,480 | 0.54% | $43.99M | +2,204,893 | 0.00% |
| Woodline Partners LP | 2,207,293 | 0.51% | $41.94M | New | 0.13% |
| Frazier Life Sciences Management, L.P. | 1,902,320 | 0.44% | $36.14M | – | 0.79% |
| Bamco Inc /Ny/ | 1,623,694 | 0.38% | $30.85M | −34,624 | 0.05% |
| Two Sigma Investments, LP | 1,299,394 | 0.30% | $24.69M | +989,671 | 0.02% |
| Citadel Advisors LLC | 1,284,706 | 0.30% | $24.41M | −403,926 | 0.00% |
| Rock Springs Capital Management LP | 814,707 | 0.19% | $15.48M | – | 0.76% |
| BlackRock, Inc. | 664,462 | 0.15% | $12.62M | −200,684 | 0.00% |
| C WorldWide Group Holding A/S | 510,000 | 0.12% | $9.69M | – | 0.23% |
| Jane Street Group, LLC | 476,541 | 0.11% | $9.05M | +208,615 | 0.00% |
| B Group, Inc. | 450,646 | 0.10% | $8.56M | – | 4.02% |
| Nantahala Capital Management, LLC | 400,000 | 0.09% | $7.60M | New | 0.13% |
| Schroder Investment Management Group | 393,167 | 0.09% | $7.24M | – | 0.01% |
| Nan Fung Trinity (Hk) Ltd | 346,466 | 0.08% | $6.58M | – | 0.65% |
| abrdn plc | 311,294 | 0.07% | $5.91M | +73,555 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 93 | 43M | 10.1% | 16 / 28 | 29 / 21 | 17M | 2M |
| Q1 2026 | 99 | 28M | 6.6% | 17 / 26 | 43 / 42 | 8M | 9M |
| Q4 2025 | 126 | 29M | 6.7% | 33 / 36 | 40 / 44 | 11M | 17M |
| Q3 2025 | 138 | 35M | 8.2% | 21 / 48 | 46 / 38 | 4M | 11M |
| Q2 2025 | 156 | 43M | 9.9% | 33 / 49 | 59 / 36 | 6M | 20M |
| Q1 2025 | 160 | 56M | 13.1% | 46 / 48 | 46 / 16 | 11M | 11M |
| Q4 2024 | 131 | 56M | 13.1% | 37 / 46 | 35 / 9 | 20M | 9M |
| Q3 2024 | 104 | 45M | 10.6% | 17 / 36 | 33 / 17 | 10M | 5M |
| Q2 2024 | 105 | 41M | 9.5% | 13 / 36 | 39 / 22 | 5M | 4M |
| Q1 2024 | 117 | 42M | 9.7% | 18 / 44 | 33 / 24 | 7M | 6M |
| Q4 2023 | 124 | 42M | 9.7% | 22 / 34 | 44 / 19 | 7M | 5M |
| Q3 2023 | 122 | 39M | 9.2% | 12 / 39 | 54 / 27 | 3M | 7M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
33 funds held ZLAB in Q2 2026, 20% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ZLAB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Baron Emerging Markets Fund | 1,370,904 | 0.32% | $26.05M | 0.65% | Jun 30, 2026 |
| Strategic Advisers Fidelity Emerging Markets Fund | 738,509 | 0.17% | $13.06M | 0.03% | May 31, 2026 |
| iShares Biotechnology ETF | 633,528 | 0.15% | $12.04M | 0.13% | Jun 30, 2026 |
| Fidelity Growth Company Fund | 332,190 | 0.08% | $5.88M | 0.01% | May 31, 2026 |
| Strategic Advisers Emerging Markets Fund | 204,400 | 0.05% | $3.62M | 0.02% | May 31, 2026 |
| Tema Oncology ETF | 196,972 | 0.05% | $3.48M | 1.98% | May 31, 2026 |
| Fidelity Growth Company K6 Fund | 131,934 | 0.03% | $2.33M | 0.01% | May 31, 2026 |
| ALPS Medical Breakthroughs ETF | 115,031 | 0.03% | $2.03M | 1.26% | May 31, 2026 |
| Baron International Growth Fund | 81,821 | 0.02% | $1.55M | 0.48% | Jun 30, 2026 |
| Virtus Biotech Etf | 79,505 | 0.02% | $1.45M | 1.47% | Jul 31, 2026 |
| Fidelity Series Growth Company Fund | 77,700 | 0.02% | $1.37M | 0.01% | May 31, 2026 |
| Destinations International Equity Fund | 75,566 | 0.02% | $1.34M | 0.06% | May 31, 2026 |
| Dimensional Emerging Markets Core Equity 2 ETF | 26,020 | 0.01% | $475.39K | 0.01% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 23,879 | 0.01% | $422.42K | 0.00% | May 31, 2026 |
| Emerging Markets Core Equity 2 Portfolio | 22,834 | 0.01% | $417.18K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ying Du | Chairperson & CEO, Director | 1,226,224 | 0.28% | Jul 6, 2026 |
| Yajing Chen | Chief Financial Officer | 36,240 | 0.01% | Oct 5, 2026 |
| Frazor Titus Edmondson III | Chief Legal Officer | 30,346 | 0.01% | Jun 29, 2026 |
| Yizhe Wang | Operating Partner | – | – | Jun 8, 2026 |
| Joshua L. Smiley | See Remarks | 117,602 | 0.03% | Apr 8, 2026 |
| Rafael Amado | See Remarks | 57,022 | 0.01% | Apr 8, 2026 |
| Richard Gaynor | Director | 81,965 | 0.02% | Nov 13, 2026 |
| William Lis | Director | 41,931 | 0.01% | Aug 13, 2026 |
| Michel Vounatsos | Director | 72,787 | 0.02% | Jun 22, 2026 |
| Scott W. Morrison | Director | 56,904 | 0.01% | Jun 22, 2026 |
| John D. Diekman | Director | 122,140 | 0.03% | Jun 22, 2026 |
| Leon O. Moulder Jr | Director | 94,973 | 0.02% | Jun 22, 2026 |
| Peter Wirth | Director | 420,121 | 0.10% | Jun 22, 2026 |
| Nisa Leung | Director | 8,019,229 | 1.86% | Jun 22, 2026 |
| Kai-Xian Chen | Director | 39,525 | 0.01% | Jan 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Richard Gaynor Director | Nov 10, 2026 | Buy | +1,228 | $27.19 | $33.39K | 81,965 |
| Yajing Chen Chief Financial Officer | Oct 1, 2026 | Tax withholding | −315 | $25.50 | $8.03K | 36,240 |
| Yajing Chen Chief Financial Officer | Oct 1, 2026 | Option exercise | +920 | – | – | 36,555 |
| Yajing Chen Chief Financial Officer | Aug 19, 2026 | Sale(10b5-1 plan) | −260 | $27.00 | $7.02K | 35,635 |
| Yajing Chen Chief Financial Officer | Aug 14, 2026 | Tax withholding | −427 | $25.90 | $11.06K | 35,895 |
| Yajing Chen Chief Financial Officer | Aug 14, 2026 | Option exercise | +1,250 | – | – | 36,322 |
| William Lis Director | Aug 12, 2026 | Sale(10b5-1 plan) | −8,506 | $25.00 | $212.65K | 41,931 |
| Yajing Chen Chief Financial Officer | Aug 11, 2026 | Sale(10b5-1 plan) | −619 | $25.00 | $15.48K | 35,072 |
| Ying Du Chairperson & CEO, Director | Jul 2, 2026 | Option exercise | +11,048 | – | – | 1,225,749 |
| Ying Du Chairperson & CEO, Director | Jul 2, 2026 | Tax withholding | −4,348 | $19.12 | $83.13K | 1,221,401 |
| Ying Du Chairperson & CEO, Director | Jul 1, 2026 | Option exercise | +18,000 | – | – | 1,221,784 |
| Ying Du Chairperson & CEO, Director | Jul 1, 2026 | Tax withholding | −7,083 | $19.15 | $135.64K | 1,214,701 |
| Richard Gaynor Director | Jul 1, 2026 | Buy | +1,736 | $19.05 | $33.07K | 80,737 |
| Ying Du Chairperson & CEO, Director | Jun 30, 2026 | Sale | −7,026 | $18.53 | $130.19K | 1,203,784 |
| Ying Du Chairperson & CEO, Director | Jun 29, 2026 | Option exercise | +17,970 | – | – | 1,210,810 |
| Ying Du Chairperson & CEO, Director | Jun 26, 2026 | Sale | −24,543 | $17.46 | $428.52K | 1,192,840 |
| Frazor Titus Edmondson III Chief Legal Officer | Jun 26, 2026 | Sale | −4,103 | $17.46 | $71.64K | 30,346 |
| Yajing Chen Chief Financial Officer | Jun 26, 2026 | Sale | −2,264 | $17.46 | $39.53K | 35,691 |
| Ying Du Chairperson & CEO, Director | Jun 25, 2026 | Option exercise | +58,800 | – | – | 1,217,383 |
| Frazor Titus Edmondson III Chief Legal Officer | Jun 25, 2026 | Option exercise | +14,600 | – | – | 34,449 |
| Yajing Chen Chief Financial Officer | Jun 25, 2026 | Option exercise | +6,250 | – | – | 37,955 |
| William Lis Director | Jun 22, 2026 | Sale(10b5-1 plan) | −7,040 | $18.09 | $127.35K | 50,437 |
| Michel Vounatsos Director | Jun 17, 2026 | Award | +22,371 | – | – | 72,787 |
| Richard Gaynor Director | Jun 17, 2026 | Award | +22,371 | – | – | 79,001 |
| Peter Wirth Director | Jun 17, 2026 | Award | +22,371 | – | – | 416,121 |
| Scott W. Morrison Director | Jun 17, 2026 | Award | +22,371 | – | – | 56,904 |
| William Lis Director | Jun 17, 2026 | Award | +22,371 | – | – | 57,477 |
| Leon O. Moulder Jr Director | Jun 17, 2026 | Award | +22,371 | – | – | 94,973 |
| John D. Diekman Director | Jun 17, 2026 | Award | +22,371 | – | – | 122,140 |
| Nisa Leung Director | Jun 17, 2026 | Award | +22,371 | – | – | 96,297 |
| Ying Du Chairperson & CEO, Director | May 27, 2026 | Gift | −53,850 | – | – | 1,158,583 |
| Ying Du Chairperson & CEO, Director | May 27, 2026 | Gift | −33,993 | – | – | 1,212,433 |
| Ying Du Chairperson & CEO, Director | May 26, 2026 | Gift | −19,857 | – | – | 1,246,426 |
| Ying Du Chairperson & CEO, Director | May 19, 2026 | Option exercise | +261,092 | $1.74 | $454.30K | 1,383,718 |
| Ying Du Chairperson & CEO, Director | May 19, 2026 | Tax withholding | −117,435 | $18.75 | $2.20M | 1,266,283 |
| Ying Du Chairperson & CEO, Director | May 18, 2026 | Sale(10b5-1 plan) | −50,000 | $19.00 | $950.00K | 1,122,626 |
| Ying Du Chairperson & CEO, Director | May 18, 2026 | Option exercise | +50,000 | $1.74 | $87.00K | 1,172,626 |
| Ying Du Chairperson & CEO, Director | May 15, 2026 | Sale(10b5-1 plan) | −50,000 | $20.74 | $1.04M | 1,122,626 |
| Ying Du Chairperson & CEO, Director | May 15, 2026 | Option exercise | +50,000 | $1.74 | $87.00K | 1,172,626 |
| Frazor Titus Edmondson III Chief Legal Officer | May 14, 2026 | Sale(10b5-1 plan) | −3,517 | $20.19 | $71.01K | 19,849 |
| Ying Du Chairperson & CEO, Director | May 14, 2026 | Sale(10b5-1 plan) | −50,000 | $20.09 | $1.00M | 1,122,626 |
| Ying Du Chairperson & CEO, Director | May 14, 2026 | Option exercise | +50,000 | $1.74 | $87.00K | 1,172,626 |
| Ying Du Chairperson & CEO, Director | May 13, 2026 | Sale(10b5-1 plan) | −33,769 | $20.22 | $682.81K | 1,122,626 |
| Ying Du Chairperson & CEO, Director | May 13, 2026 | Sale(10b5-1 plan) | −16,231 | $19.44 | $315.53K | 1,156,395 |
| Ying Du Chairperson & CEO, Director | May 13, 2026 | Option exercise | +50,000 | $1.74 | $87.00K | 1,172,626 |
| Rafael Amado See Remarks | Apr 6, 2026 | Sale | −2,739 | $20.45 | $56.01K | 57,022 |
| Frazor Titus Edmondson III Chief Legal Officer | Apr 6, 2026 | Sale | −1,224 | $20.45 | $25.03K | 23,366 |
| Yajing Chen Chief Financial Officer | Apr 6, 2026 | Sale | −853 | $20.45 | $17.44K | 31,705 |
| Ying Du Chairperson & CEO, Director | Apr 6, 2026 | Sale | −2,653 | $20.45 | $54.25K | 1,122,626 |
| Joshua L. Smiley See Remarks | Apr 6, 2026 | Sale | −3,017 | $20.45 | $61.70K | 117,602 |
| Ying Du Chairperson & CEO, Director | Apr 2, 2026 | Option exercise | +6,750 | – | – | 1,130,855 |
| Ying Du Chairperson & CEO, Director | Apr 2, 2026 | Sale | −5,576 | $20.39 | $113.69K | 1,125,279 |
| Yajing Chen Chief Financial Officer | Apr 2, 2026 | Sale | −5,199 | $20.39 | $106.01K | 32,558 |
| Yajing Chen Chief Financial Officer | Apr 2, 2026 | Option exercise | +2,500 | – | – | 37,757 |
| Frazor Titus Edmondson III Chief Legal Officer | Apr 2, 2026 | Sale | −4,194 | $20.39 | $85.52K | 24,590 |
| Frazor Titus Edmondson III Chief Legal Officer | Apr 2, 2026 | Option exercise | +5,031 | – | – | 28,784 |
| Rafael Amado See Remarks | Apr 2, 2026 | Option exercise | +5,391 | – | – | 69,671 |
| Rafael Amado See Remarks | Apr 2, 2026 | Sale | −9,910 | $20.39 | $202.06K | 59,761 |
| Joshua L. Smiley See Remarks | Apr 2, 2026 | Option exercise | +7,145 | – | – | 130,233 |
| Joshua L. Smiley See Remarks | Apr 2, 2026 | Sale | −9,614 | $20.39 | $196.03K | 120,619 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Zai Lab's stock actually held short. Settlement fails (shares not delivered on time) peaked at 22,070 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Joshua L. Smiley Former Officer | Aug 20, 2026 | 98,653 | $2.58M | Aug 20, 2026 | Stock Option Exercise |
| Yajing Chen Officer | Aug 19, 2026 | 260 | $7.02K | Aug 19, 2026 | Restricted Stock Vesting |
| William Lis Director | Aug 12, 2026 | 8,506 | $212.65K | Aug 12, 2026 | Restricted Stock Vesting |
| Yajing Chen Officer | Aug 11, 2026 | 619 | $15.48K | Aug 11, 2026 | Restricted Stock Vesting |
| Ying Du Officer, Director | Jun 30, 2026 | 7,026 | $130.22K | Jun 30, 2026 | Restricted Stock Vesting |
| Ying Du Officer, Director | Jun 26, 2026 | 24,543 | $428.55K | Jun 26, 2026 | Restricted Stock Vesting |
| Frazor Titus Edmondson III Officer | Jun 26, 2026 | 4,103 | $71.64K | Jun 26, 2026 | Restricted Stock Vesting |
| Yajing Chen Officer | Jun 26, 2026 | 2,264 | $39.53K | Jun 26, 2026 | Restricted Stock Vesting |
| William Lis Director | Jun 22, 2026 | 7,040 | $127.35K | Jun 22, 2026 | Restricted Stock Vesting |
| Ying Du Officer, Director | May 18, 2026 | 50,000 | $976.00K | May 18, 2026 | Option Granted - 08/25/2016 |
| Ying Du Officer, Director | May 15, 2026 | 50,000 | $1.02M | May 15, 2026 | Option Granted - 08/25/2016 |
| Frazor Titus Edmondson III Officer | May 14, 2026 | 3,517 | $71.01K | May 14, 2026 | Restricted Stock Vesting |
| Ying Du Officer, Director | May 14, 2026 | 50,000 | $1.00M | May 14, 2026 | Option Granted - 08/25/2016 |
| Ying Du Officer, Director | May 13, 2026 | 50,000 | $960.00K | May 13, 2026 | Option Granted - 08/25/2016 |
| Joshua L. Smiley Officer | Apr 6, 2026 | 3,017 | $61.69K | Apr 6, 2026 | Restricted Stock Vesting |
See a number that looks wrong?